Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Glycoproteomics profiling of recombinant SARS-CoV-2 stabilized Spike construct

ABSTRACT: N-linked glycans of recombinant SARS-CoV-2 Spike protein with stabilizing mutations were profiled by LC-MS/MS.

INSTRUMENT(S): Orbitrap Fusion

ORGANISM(S): Severe Acute Respiratory Syndrome Coronavirus 2

SUBMITTER: Joost Snijder

LAB HEAD: Joost Snijder

PROVIDER: PXD025554 | Pride | 2021-07-28

REPOSITORIES: pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	DB_SARS-CoV-2_Spike-5P_Proteases.fasta	Fasta
	DB_SARS-CoV-2_Spike-VFLIP_Proteases.fasta	Fasta
	SARS-CoV-2_Spike_5P_HEK_aLP_01.raw	Raw
	SARS-CoV-2_Spike_5P_HEK_aLP_01.raw_Byonic.zip	Raw
	SARS-CoV-2_Spike_5P_HEK_aLP_02.raw	Raw

Items per page:

1 - 5 of 38

Similar Datasets

Glycan shield of the ebolavirus envelope glycoprotein GP

Project description:The envelope glycoprotein GP of the ebolaviruses is essential for host cell attachment and entry. It is also the primary target of the protective and neutralizing antibody response in both natural infection and vaccination. GP is heavily glycosylated with up to 17 predicted N-linked sites, numerous O-linked glycans in its disordered mucin-like domain (MLD), and three predicted C-linked mannosylation sites. Glycosylation of GP is important for host cell attachment to cell-surface lectins, as well as GP stability and fusion activity. Moreover, it has been shown to shield GP from neutralizing activity of serum antibodies. Here, we use mass spectrometry-based glycoproteomics to profile the site-specific glycosylation patterns of ebolavirus GP, including N-, O-, and C-linked glycans.

2022-08-02 | PXD031459 | Pride

Glycoproteomics of recombinant Measles Virus F from Drosophila S2 cells

Project description:Recombinant soluble ectodomains of a prefusion-stabilized MeV F-protein were analysed by bottom-up proteomics to profile the N-glycans.

2025-01-02 | PXD050366 | Pride

Allotype-specific glycosylation and cellular localization of HLA class I proteins

Project description:Presentation of self- and foreign peptide antigens by human leukocyte antigen (HLA) complexes at the cell surface is a key process in our immune response. The alpha-chain, the part of the HLA class I complex that contains the peptide binding groove, is one of the most polymorphic proteins in the human proteome. All HLA class I alpha-chains carry a conserved N-glycosylation site, but little is known about its nature and function. Here, we report an in-depth characterization of the N-glycosylation features in HLA class I molecules. In three cell lines we observe that different HLA-A alpha-chains carry similar glycosylation, distinctly different from the HLA-B, HLA-C and HLA-F alpha-chains. HLA-B alpha-chains carry mostly mature glycans, HLA-C and HLA-F alpha-chains carry predominantly high-mannose, whereas HLA-A molecules display the broadest variety of glycan characteristics. We hypothesized that these glycosylation features are directly linked to the cellular localization of the HLA complexes. Analyzing HLA class I complexes from plasma and inner membrane enriched fractions revealed confirmed that most HLA-B complexes can be found in the plasma membrane, most HLA-C and HLA-F molecules reside in the ER and Golgi membrane and HLA-A molecules are more equally distributed over all these cellular compartments. As peptide-binding and specificity is cellular compartment dependent, we corroborate from our data that standard measurements of HLA peptide-antigens from whole cell extracts likely do not exclusively capture the antigen repertoires presented at the cell surface, but also those still within the cell. Our data indicate that standard protein quantification of HLA alpha-chains does not correlate with cell surface expression levels, while analysis of glycopeptides provides allotype and compartment specific quantification.

2022-02-17 | PXD023684 | Pride

Glycosylation profiling of 87G7

Project description:Comparison of the glycosylation profile of monoclonal anti-SARS-CoV-2 Spike IgG (87G7) produced in human or fungal expression platforms

2024-03-18 | PXD041208 | Pride

Site-specific N-linked glycosylation of recombinant SARS-CoV-1 and -2 Receptor Binding Domain from GnTI-/- cells

Project description:Fusion proteins of the SARS-CoV-1 and SARS-CoV-2 spike receptor binding domain with a fluorescent protein were created in monomeric and trimeric form as tools for receptor binding studies in cultured cells and animal tissues. Here, site specific N-linked glycosylation in the proteins expressed from GnTI-/- cells is profiled with LC-MS/MS, using electron transfer high-energy collision dissociation

2021-02-02 | PXD021825 | Pride

Plant UDP-N-acetylglucosamine (UDP-GlcNAc) transporter (UGNT1) glycopeptide analysis

Project description:Glycosylation reactions require activated glycosyl donors in form of nucleotide sugars to drive processes such as post-translational protein modifications, glycolipid and polysaccharide biosynthesis. Most of these reactions occur in the Golgi requiring cytosolic-derived nucleotide sugars, which are actively transferred into the Golgi lumen by nucleotide sugar transporters. Here we present the identification of the plant UDP-N-acetylglucosamine (UDP-GlcNAc) transporter (UGNT1) indispensable for the delivery of a substrate for maturation of N-glycans and glycosyl inositol phosphorylceramides (GIPCs). Profiles of N-glycopeptides revealed that UGNT1 loss-of-function mutants are devoid of complex and hybrid N-glycans. Instead, most of the glycol-N-peptide population contained high mannose structures, representing the structure prior to the addition of the first GlcNAc in the Golgi. Our findings emphasize that the reference plant Arabidopsis contains a single UDP-GlcNAc transporter responsible for the maturation of complex N-glycans in the Golgi lumen.

2018-09-24 | PXD006635 | Pride

Intact N-glycopeptides in Serum Haptoglobin between HCC and Cirrhosis

Project description:A workflow for differential analysis of the microheterogeneity of site-specific intact N-glycopeptides of serum haptoglobin between early hepatocellular carcinoma (HCC) and liver cirrhosis has been developed.

2018-10-25 | PXD011239 | Pride

Glycopeptide Biomarkers for HCC Detection in Patients with NASH

Project description:A comprehensive screening of site-specific N-glycopeptides in serum haptoglobin (Hp), a reporter molecule for aberrant glycosylation in HCC, has been performed to characterize glycopeptide markers for NASH-related HCCs.

2020-05-22 | PXD018502 | Pride

N-linked glycosylation of recombinant soluble ectodomain of HKU1 haemagglutinin esterase

Project description:Coronaviruses (CoVs) encompass many human pathogens such as HKU-1, OC43, NL63, SARS, MERS and, most recently, nCoV-2019. The spike (S) protein of CoVs has received much attention for its role in host tropism and immunity, but it is becoming increasingly clear that the haemagglutinin esterase (HE) also plays an important role in host adaptation by determining host receptor (sialic acid) specificity. We determined the structure of HKU1 HE by cryo electron microscopy and mapped site-specific N-linked glycosylation by LC-MS/MS of glycopeptides using electron transfer high-energy collision dissociation.

2020-07-24 | PXD017545 | Pride

Absence of the dolichol synthesis gene DHRSX leads to N-glycosylation defects in Lec5 and Lec9 Chinese hamster ovary cells

Project description:Glycosylation-deficient Chinese hamster ovary (CHO) cell lines have been instrumental in the discovery of N-glycosylation machinery. Yet, the molecular causes of the glycosylation defects in the Lec5 and Lec9 mutants have been elusive, even though for both cell lines a defect in dolichol formation from polyprenol was previously established. We recently found that dolichol synthesis from polyprenol occurs in three steps consisting of the conversion of polyprenol to polyprenal by DHRSX, the reduction of polyprenal to dolichal by SRD5A3 and the reduction of dolichal to dolichol, again by DHRSX.This led us to investigate defective dolichol synthesis in Lec5 and Lec9 cells. Both cell lines showed increased levels of polyprenol and its derivatives, concomitant with decreased levels of dolichol and derivatives, but no change in polyprenal levels, suggesting DHRSX deficiency. Accordingly, N-glycan synthesis and changes in polyisoprenoid levels were corrected by complementation with human DHRSX but not with SRD5A3. Furthermore, the typical polyprenol dehydrogenase and dolichal reductase activities of DHRSX were absent in membrane preparations derived from Lec5 and Lec9 cells, while the reduction of polyprenal to dolichal, catalyzed by SRD5A3, was unaffected. Long-read whole genome sequencing of Lec5 and Lec9 cells did not reveal mutations in the ORF of SRD5A3, but the genomic region containing DHRSX was absent. Lastly, we established the sequence of Chinese hamster DHRSX and validated that this protein has similar kinetic properties to the human enzyme. Our work therefore identifies the basis of the dolichol synthesis defect in CHO Lec5 and Lec9 cells.

2024-10-14 | PXD052706 | Pride